Health Condition 1: K00-K95- Diseases of the digestive system
Conditions
Interventions
Intervention1: Group A: Group A will receive 1ml of 0.5% isobaric levobupivacaine with 25 mcg fentanyl as adjuvant as drug for segmental spinal anaesthesia
Control Intervention1: Group B: Group B will
Sponsors
Institute of Medical Sciences
Eligibility
Inclusion criteria
Inclusion criteria: Patients posted for elective laparoscopic cholecystectomy of expected duration less than 90 minutes, of either sex, in the age group of 18-50 years and American Society of Anaesthesiologists (ASA) grade I and II will be included in the study.
Exclusion criteria
Exclusion criteria: Patient refusal for participating in the study. ASA Grade III and IV patients. Patients with active cholecystitis. Patients with coagulopathy. Patients with BMI more than 35 kg per m2. Spinal deformity or previous spine surgery. Any other contraindication to central neuraxial blockade or thoracic segmental spinal anesthesia. Patients allergic to the study drugs. Requiring more than 3 attempts for the procedure.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Dose of isobaric levobupivacaine 0.5% with fentanyl as adjuvant which is required for laparoscopic cholecystectomyTimepoint: 0, 5, 10, 15, 20, 30, 40, 50, 60, 75, 90 AND 120 MINUTES | — |
Secondary
| Measure | Time frame |
|---|---|
| Dermatomal mapping at onset of anaesthesia. Dermatomal regression at 30 minutes, 60 minutes, 90 minutes and 120 minutes. Surgeon comfortability score using Likhert scale. Timepoint: 0, 5, 10, 15, 20, 30, 40, 50, 60, 75, 90 AND 120 MINUTES | — |
Countries
India
Contacts
Public ContactAmrita Rath
Institute of Medical Sciences BHU
Outcome results
None listed